April 4, 2019
On April 9, a congressional hearing will explore the impact of pharmacy benefit managers on high drug prices.
March 21, 2019
As the European Union edges toward parliamentary elections, patient advocates have a message for candidates: Prioritize heart health.
March 20, 2019
It happened again just last week. A patient cried as she explained to me that she can’t afford the out-of-pocket cost of her medicine.
March 14, 2019
Suffered a heart attack? Diagnosed with cardiovascular disease? Confirmed you have genetic high cholesterol? None of that may matter…
March 14, 2019
A national data supplier reviewed PCSK9 inhibitor claims for Medicare, Medicaid, Medicaid managed care, and commercial managed care organizations across…
February 8, 2019
More than 50 percent of Europeans have raised cholesterol, increasing their risk of heart attack, stroke and death – and costing the EU billions every year in health care expenses and lost productivity. So explains a new “Fast Facts” policy brief from the European Alliance for Patient Access, a division of the Global Alliance for Patient Access.
January 31, 2019
England has a plan. It’s comprehensive, long term and aimed at preventing 150,000 heart attacks and strokes over the next 10 years. How? By, among other measures, reducing high cholesterol, hypertension and atrial fibrillation.
December 4, 2018
New clinical guidelines for cholesterol treatment could be a good thing for both physicians and patients, so long as they are used properly.
October 26, 2018
Patient advocates across the country cheered this week as news spread about a decrease in the list price of evolocumab.
October 11, 2018
Heart disease patients, providers, caregivers and stakeholders agree: Health plan policies that delay access to life-saving medication are unacceptable.
